M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study

por Ling, Leona E., Hillson, Jan L., Tiessen, Renger G., Bosje, Tjerk, van Iersel, Mattheus Paulus, Nix, Darrell J., Markowitz, Lynn, Cilfone, Nicholas A., Duffner, Jay, Streisand, James B., Manning, Anthony M., Arroyo, Santiago
Publicado 2018

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

por Trachtman, Howard, Fervenza, Fernando C, Gipson, Debbie S, Heering, Peter, Jayne, David R W, Peters, Harm, Rota, Stefano, Remuzzi, Giuseppe, Rump, L Christian, Sellin, Lorenz K, Heaton, Jeremy P W, Streisand, James B, Hard, Marjie L, Ledbetter, Steven R, Vincenti, Flavio
Publicado 2011